The short version
- A 2002 meta-analysis of 15 randomised trials in 618 participants found no association between chromium supplementation and glucose or insulin concentrations in people without diabetes.
- A 2007 systematic review of 41 randomised trials found chromium improved HbA1c by 0.6% and fasting glucose by 1.0 mmol/L in people with type 2 diabetes, and had no significant effect in people without diabetes.
- In that same review, larger effects were more commonly observed in the poor-quality studies, and almost half of the 41 trials were rated poor quality.
- There is no agreed clinical test for chromium status, so the deficiency argument used to sell it cannot be checked before or after you take it.
- A 2013 meta-analysis of 11 trials found chromium produced a mean weight difference of -0.50 kg versus placebo, with high heterogeneity and reported side effects including watery stools, vertigo and headaches.
There is a specific sentence in the chromium literature that a product page will never quote, and it is the most useful thing in the entire evidence base: “There was no benefit in individuals without diabetes.”
That is the 2007 Diabetes Care systematic review by Balk and colleagues, which pulled together 41 randomised trials. It is not an outlier finding. It is the second review in five years to land in the same place.
Two reviews, one split verdict
The earlier one, published in the American Journal of Clinical Nutrition in 2002, identified 20 randomised trials and pooled adequate data from 15, covering 618 participants — 193 with type 2 diabetes and 425 who were healthy or had impaired glucose tolerance. The meta-analysis found no association between chromium and glucose or insulin concentrations in the non-diabetic subjects. Among the diabetic participants, one study of 155 people in China reported reductions in glucose and insulin; the combined data from the other 38 diabetic subjects across all remaining trials did not. Three trials measured HbA1c, and only that same Chinese study found a significant reduction.
The 2007 review was larger and reached the same shape of conclusion with more precision. Among participants with type 2 diabetes, chromium improved HbA1c by -0.6% and fasting glucose by -1.0 mmol/L, but did not move lipids. In people without diabetes there was no significant effect on either glucose or lipid metabolism. Almost half the 41 included studies were of poor quality, and the reviewers noted something worth carrying with you: larger effects were more commonly observed in the poor-quality studies.
That is the signature of an effect that shrinks as the methods improve.
The problem nobody has solved
Chromium is sold on a deficiency logic — your soil is depleted, your diet is refined, therefore top up. It is a tidy story with one hole in it. The 2007 reviewers listed, among the limitations of the entire field, a lack of consensus on assessment of chromium status. There is no agreed test that tells you whether you personally are short of it.
So the deficiency argument cannot be checked, either before you buy or after. You cannot get a chromium panel the way you can get a ferritin or a vitamin D level, decide on the basis of a number, and re-test in three months to see whether the capsule did anything. Every other useful supplement decision we write about runs on that loop. This one cannot.
And the weight-loss claim
Chromium picolinate has a second career on the weight-loss shelf, and it has been measured there too. A 2013 meta-analysis in Obesity Reviews identified 39 randomised trials, included 20, and pooled 11. The result was a mean difference of -0.50 kg in favour of chromium over placebo, with high statistical heterogeneity. Reported adverse events included watery stools, vertigo, headaches and urticaria. The authors' own summary: the magnitude of the effect is small and the clinical relevance is uncertain.
Half a kilogram. Across trials that disagreed with each other. That is a real number and it is not a reason to buy anything.
Where this leaves you
If your fasting glucose and HbA1c are in range, the pooled evidence says chromium will do nothing measurable for them, and it says so twice. That is unusually clear for a supplement, and we would rather you heard it from us than worked it out after four months of capsules.
If your glucose is not in range, you are in a different conversation and it is a medical one. Type 2 diabetes and prediabetes are diagnoses, they are managed by a clinician with tools that have far better evidence than this, and the chromium data — one dominant trial, high heterogeneity, effects that fade in the better studies — is nowhere near strong enough to belong in that plan without your doctor putting it there. Supplements support normal metabolic function. They do not manage a diagnosis.
If you want to look at your glucose anyway
Two adjacent things are worth more of your attention than this mineral.
The first is measurement discipline. If you are going to run an experiment on your own metabolism, run it on numbers that exist — fasting glucose and HbA1c from a lab, before and after, twelve weeks apart. A continuous glucose monitor will show you far more detail than that and tempt you to over-interpret every peak, which is its own trap.
The second is knowing which ingredients in this space actually have pooled numbers behind them and how small those numbers are. Cinnamon has a genuine fasting-glucose signal in one meta-analysis and none in the Cochrane review published a year earlier. Berberine has the largest effect sizes of anything on the shelf and the poorest absorption. Neither of them is a reason to skip a doctor's appointment, and neither is chromium.
What we'd actually tell you
We do not sell chromium and this article is part of the reason. If you already own a bottle, finishing it is unlikely to hurt you. Re-ordering it, on the strength of a literature that finds nothing in people like you, is spending money on a hypothesis that has already been tested twice.
Good questions
Does chromium help lower blood sugar?
In people with type 2 diabetes, pooled trials show a modest improvement in HbA1c and fasting glucose. In people without diabetes, two separate systematic reviews found no effect at all. So the honest answer depends entirely on which group you are in, and if you are in the first group this belongs in a conversation with your doctor rather than a shopping cart.
How do I know if I am low in chromium?
You cannot find out reliably, and that is a real problem with the whole category. Reviewers of this literature have specifically flagged the lack of consensus on how to assess chromium status. Without a test, you cannot establish a deficiency before supplementing or confirm you corrected one afterwards, which makes the deficiency argument unfalsifiable rather than proven.
Will chromium picolinate help me lose weight?
Barely, if at all. The pooled result across 11 trials is half a kilogram against placebo, with high disagreement between studies and side effects including loose stools and headaches. Half a kilogram is inside the range your weight fluctuates within a normal week. We would not spend money on it and we do not stock it.
Does chromium help with sugar cravings?
The trials that exist measured glucose, insulin, HbA1c and body weight, not cravings. There is no pooled evidence base for the craving claim, which is why you see it on labels rather than in reviews. If cravings are your issue, protein at breakfast has considerably better published support than any mineral.
Is chromium safe to take?
At supplemental doses it is generally well tolerated, and the reported side effects in trials were mild — watery stools, headaches, vertigo, hives. The safety question is not really the issue here. The issue is that in people with normal glucose it has repeatedly measured as doing nothing, so you are accepting even a small risk for no documented return.
Should I take chromium if I have prediabetes?
Ask your doctor, and do not start on your own. The pooled trials in people with impaired glucose tolerance did not show a benefit, and prediabetes is a clinical finding that deserves a proper plan rather than a supplement bought on a hunch. The interventions with the strongest evidence in that situation are not sold in capsules.
Sources
- Althuis MD, Jordan NE, Ludington EA, Wittes JT. Glucose and insulin responses to dietary chromium supplements: a meta-analysis. Am J Clin Nutr, 2002. View study
- Balk EM, Tatsioni A, Lichtenstein AH, Lau J, Pittas AG. Effect of chromium supplementation on glucose metabolism and lipids: a systematic review of randomized controlled trials. Diabetes Care, 2007. View study
- Onakpoya I, Posadzki P, Ernst E. Chromium supplementation in overweight and obesity: a systematic review and meta-analysis of randomized clinical trials. Obes Rev, 2013. View study
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
